AbCellera Biologics Inc. ABCL Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
Based on trailing twelve months.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s free cash flow yield?
- AbCellera Biologics Inc. (ABCL) reported free cash flow yield of -17.9% in Q1 2026.
- How has AbCellera Biologics Inc.'s free cash flow yield changed year-over-year?
- AbCellera Biologics Inc.'s free cash flow yield increased by 17.1% year-over-year, from -21.6% to -17.9%.
- What is the long-term trend for AbCellera Biologics Inc.'s free cash flow yield?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s free cash flow yield has grown at a 52.7% compound annual growth rate (CAGR), from -7.3% to -17%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.